Successful treatment of pityriasis rubra pilaris with guselkumab: Serum CCL20 as a potential marker for the disease activity

Dermatol Ther. 2020 Nov;33(6):e14403. doi: 10.1111/dth.14403. Epub 2020 Oct 21.

Authors

Hiroshi Nagai¹, Haruki Jimbo¹, Shoko Matsuura¹, Saori Tatsuoka¹, Erina Shiraki¹, Chikako Nishigori¹

Affiliation

¹ Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.

PMID: 33044038
DOI: 10.1111/dth.14403

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Chemokine CCL20 / blood
Female
Humans
Middle Aged
Pityriasis Rubra Pilaris* / diagnosis
Pityriasis Rubra Pilaris* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
CCL20 protein, human
Chemokine CCL20
guselkumab